Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma

doi:10.3748/wjg.v18.i42.6005

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9215)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

823

HTML

7765

Figures (1-8)

441

Tables (1-3)

186

Sum=9215

Nov 14, 2012 (publication date) through Aug 27, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Nov 14, 2012; 18(42): 6005-6017
Published online Nov 14, 2012. doi: 10.3748/wjg.v18.i42.6005

Full Size Figure Download Figure

Figure 5 Mammalian target of rapamycin/hypoxia-inducible factor-1/vascular endothelial growth factor signaling pathway in angiogenesis in solid cancer. HIF: Hypoxia-inducible factor; VEGF: Vascular endothelial growth factor; mTOR: Mammalian target of rapamycin; FKBP12: FK506-binding protein 12.

Citation: Kudo M. Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma. World J Gastroenterol 2012; 18(42): 6005-6017
URL: https://www.wjgnet.com/1007-9327/full/v18/i42/6005.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i42.6005